expert witness,DUI,toxicology,pharmacology,expert witness testimony,litigation support  
Presentations/Abstracts
  
Home PageMy BackgroundSearchContact MePatentsPublicationsPositions HeldFaculty AppointmentsPublished ArticlesSocietiesEducationLinksLitigationPrivacy Policy/HIPPAForensic ServicesWhy Use IDDC?

1.        Dajani EZ, Studies on the pharmacology of the industrial solvent methyl cellosolve.  Society of Experimental Biology and Medicine.  Indianapolis, Indiana.  October 1968.

 

  2.      Dajani EZ, Mennear JH: Gas chromatographic assay for ethylene glycol monomethyl ester.  Toxicol Appl Pharmacol 14(3): 618, 1969.

 

  3.      Dajani EZ: Experimental cholelithiasis: Studies on the mouse and hamster gallstone models.  An invited lecture presented at the Gastrointestinal Pharmacology Group Symposium on Bile.  Philadelphia, Pennsylvania.  November 1970.

 

  4.      Dajani EZ: The technicians' role in toxicological studies.  An invited lecture presented at the AALAS Symposium on Laboratory Animal Considerations in Toxicology and Related Disciplines. New Brunswick, New Jersey.  June 1972.

 

  5.      Dajani EZ: Gastric antisecretory and antiulcer actions of E-prostaglandin analogs.  An invited lecture presented at the Department of Medicine (Gastroenterology), University of California, San Francisco, California. April 1974.

 

  6.      Dajani EZ, Roge EAW, Bertermann RE: The effect of prostaglandin E1 methyl ester and diphenoxylate on canine duodenal motility in vivo.  Presented at the Midwest Pharmacology Meeting. Ann Arbor, Michigan.  May 1975.

 

  7.      Dajani EZ, Driskill DR, Bianchi RG, Collins PW, Pappo R: Studies on the biological properties of a prostaglandin analog, SC-29333, a potent inhibitor of gastric secretion.  Presented at the International Conference on Prostaglandins.  Florence, Italy.  May 1975.

 

  8.      Collins PW, Pappo R, Dajani EZ: Application of 1,4 addition reactions to the synthesis of novel prostaglandins.  Presented at the International Conference on Prostaglandins.  Florence, Italy.  May 1975.

 

  9.      Dajani EZ, Bianchi RG, Adelstein GW, Yen CH: Studies on the biological properties of SC-27166, a novel antidiarrheal agent.  Philadelphia GI Research Forum.  Philadelphia, Pennsylvania. October 1975.

 

 10.     Dajani EZ, Driskill DR, Bianchi RG, Collins PW, Pappo R: Studies on the pharmacology of SC-29333, a potent gastric antisecretory prostaglandin. Philadelphia GI Research Forum.  Philadelphia, Pennsylvania. October 1975.

 

11.           Adelstein GW, Yen CH, Dajani EZ: Synthesis and biology of a novel series of antidiarrheal agents.  Am Chem Soc Meeting.  Mexico City, Mexico, 1975.

 

 12.     Pappo R, Collins PW, Bruhn MS, Palmer JR, Dajani EZ: Synthesis and biological properties of 16-hydroxy prostaglandin analogs.  Winter Prostaglandin Conference. Vail, Colorado.  January 1976.

 

 13.     Dajani EZ, Callison DA, Bianchi RG, Driskill DR: Gastric antisecretory effects of E-prostaglandins in conscious monkeys.  Federation Proceedings 35: 539, 1976.

 

 14.     Dajani EZ: Effects of E-prostaglandins on the gastric mucosal barrier.  An invited presentation at the Gastrointestinal Pharmacology Symposium entitled "Drugs and the Gastric Mucosal Barrier."  Groton, Connecticut.  October 1976.

 

 15.     Callison DA, Dajani EZ, Bertermann RE: Effects of E-prostaglandins on canine gastric potential differences.  Federation Proceedings 36:595, 1977.

 

 16.     Dajani EZ: Drug research in the pharmaceutical industry: A pharmacologist's point of view.  An invited series of continuing medical and pharmaceutical education lectures presented at the Kuwait Ministry of Health, Kuwait.  November 1977.

 

 17.     Driskill DR, Colton DG, Phillips EL, Poy P, Dajani EZ: Effect of SC-29333 on gastric mucosal blood flow and serum gastrin in the dog. Federation Proceedings 37: 459, 1978.

 

 18.     Callison DA, Dajani EZ, Bianchi RG: Gastric antisecretory actions of propantheline bromide and metiamide in conscious rhesus monkeys.  Federation Proceedings 37: 460, 1978.

 

 19.     Dajani EZ: Perspective on the pharmacology of antidiarrheal drugs.  An invited presentation at a 1978 ASPET Symposium entitled "Current Concepts of Gastrointestinal Motility."  Atlantic City, New Jersey.  April 1978.

 

 20.     Dajani EZ, Roge EAW, Bertermann RE, Schweingruber FL: Gastrointestinal motility effects of PGF2 alpha in the dog.  7th International Congress of Pharmacology. Paris, France.  July 1978.

 

 21.     Dajani EZ, Roge EW, Bertermann RE, Schweingruber FL: Reversal of gastrointestinal motility actions of PGF2 alpha by naloxone.  7th International Congress of Pharmacology.  Paris, France.  July 1978.

 

 22.     Bianchi RG, Dajani EZ, Calhoun DW: Synergistic actions of propantheline bromide, cimetidine and thiopropazate in the prevention of stress ulcer formation in rats.  Pharmacologist 20:209, 1978.

 

 23.     Dajani EZ: Pharmacology of anticholinergic drugs.  Invited lecture presented at The Northern Illinois Orthodontic Study Group.  Chicago, Illinois.  October 1978.   

 

 24.     Adelstein GW, Yen CH, Dajani EZ, Bianchi RG: Potent analogs of Lomotil; separation of constipating and analgesic properties.  Amer Chem Soc Great Lakes Regional Meeting.  Rockford, Illinois.  June 1979.

 

  25.     Dajani EZ: Perspective on the pharmacology of gastric antisecretory

            and  antiulcer drugs.  An invited lecture presented at the Amer Chem

           Soc Symposium on Peptic Ulcer, Great Lakes Regional Meeting 

            Rockford, Illinois.  June 1979.

 

 26.     Woods EM, Dajani EZ, Roge EW, Bertermann RE, Schweingruber FL: Naloxone reversal of drug-induced diarrhea in mice.  Pharmacologist 21:175, 1979.

 

 27.     Dajani EZ, Bianchi RG, Casler JJ, Weet JF: Gastric antiulcer and antisecretory effects of carbenoxolone, aldosterone and desoxycorticosterone in rats. Pharmacologist 21:176, 1979.

 

 28.     Bianchi RG, Dajani EZ, Casler JJ, Calhoun DW: Synergistic actions of propantheline bromide with cimetidine and thiopropazate hydrochloride in the inhibition of gastric secretion in rats.  Pharmacologist 21:176, 1979.

 

 29.     Dajani EZ: Prostaglandins and the gut: An update.  An invited lecture presented at the ASPET Symposium entitled "Recent Developments in Gastrointestinal Pharmacology."  Portland, Oregon.  1979.

 

 30.     Dajani EZ: Perspective on the pharmacology of antiulcer drugs: An update.  Grand Rounds presented at the Department of Medicine, Northwestern University.  Chicago, Illinois.  November 1979.

 

 31.     Driskill DR, Dajani EZ, Phillips EL, Collins PW, Pappo R: Effects of a prostaglandin analogue, SC-30249, on canine gastric secretion.  Federation Proceedings 39(3): 563, 1980.

 

32.           Dajani EZ: Comparison between the pharmacology of gastric and duodenal antiulcer drugs.  An invited presentation at a symposium entitled "Duodenal and Gastric Ulcers - Pathogenesis and Pharmacology," co-sponsored by Society of Pathology and ASPET.  Anaheim, California.  April 1980.

 

 33.     Bianchi RG, Dajani EZ, Casler JJ: Gastric antiulcer and antisecretory effects of bismuth salts in the rat.  Pharmacologist 22:168, 1980.

 

 34.    Gullikson GW, Dajani EZ, Bianchi RG: Reversal of deoxycholate-induced intestinal fluid secretion by lidamidine.  Pharmacologist 22:168, 1980.

 

 35.     Yen CH, Bianchi RG, Dajani EZ: Synthesis and biological activities of substituted quinuclidines.  Amer Chem Soc Meeting.  Chicago, Illinois.  January 1981.

 

 36.     Dajani EZ: Pharmacology of the prostaglandin analogue SC-29333. International Congress on Stomach Diseases, University of Antwerp.  Antwerp, Belgium.  May 1981.

 

37.           Dajani EZ: Prostaglandins and the gastrointestinal tract.  Grand Rounds, Hines VA Hospital.  Hines, Illinois.  May 1981.

 

38.      Kessler L, Bianchi RG, Callison DA, Dajani EZ: Prevention of duodenal ulcer formation in the cat by E-prostaglandins.  Pharmacologist 23:121, 1981.

 

 39.     Bianchi RG, Casler JJ, Dajani EZ: Gastric antisecretory and antiulcer activity of

           SC-29333:  A synthetic E-prostaglandin analog.  Pharmacologist 23:121, 1981.

 

 40.    Gullikson GW, Jasty V, Dajani EZ: Effect of lidamidine on deoxycholate-induced histological and permeability changes in canine jejunum.  Pharmacologist 23:122, 1981.

 

 41.     Dajani EZ: Perspectives on the pharmacology of antiulcer drugs.  An invited lecture presented at a symposium entitled "Recent Advances Against Duodenal and Gastric Ulcer Disease," 13th Lithuanian American Medical Association.  Chicago, Illinois.

           September 1981.

 

 42.     Collins PW, Dajani EZ, Pappo R, Gasiecki AF, Bianchi RG, Woods EM: Synthesis and gastric antisecretory properties of 4,5-unsaturated derivatives of

           15-deoxy-16-hydroxyl-16-methyl prostaglandin E1.  Amer Chem Soc 183:62, 1982.

 

 43.     Pitzele BS, Kellar P, Kessler L, Sanner J, Woods EM, Dajani EZ: Quaternary ammonium analogs of an H2-receptor antagonist.  Amer Chem Soc 183: 58, 1982.

 

 44.     Dajani EZ: Perspectives on the pharmacology of misoprostol, a synthetic PGE1 analogue.  An invited lecture presented at the Gordon Research Conference on Medicinal Chemistry, Colby-Sawyer College.  New London, New Hampshire.  August 1982.

 

 45.     Dajani EZ, Collins PW, Bianchi RG, Woods EM, Colton DG, Driskill DR, Pappo R: Gastrointestinal pharmacology of misoprostol: A novel antiulcer agent.  Invited lecture, Department of Pharmacology, University of Wisconsin. Madison, Wisconsin.  April 1983.

 

 46.     Gullikson GW, Anglin C, Kessler L, Smeach S, Crowder S, Bauer R, Dajani EZ: Misoprostol prevents aspirin-induced damage in canine Heidenhain pouches. Gastroenterology 84:1176, 1983.

 

 47.     Dajani EZ:  Prostaglandins.  An invited presentation, Chicago Society of Gastroenterology.  Chicago, Illinois.  March 1984.

 

 48.     Dajani EZ:  Prostaglandins in gastroenterology.  An invited lecture (principal speaker), European Association for Gastro-Camera, Diagnosis and Endoscopy.  Innsbruck, Austria.  March 1984.

 

 49.     Collins PW, Gasiecki AF, Decktor D, Dajani EZ, Woods EM, Bianchi RG: Alpha chain unsaturated derivatives of 16-hydroxy prostaglandins. Amer Chem Soc, National Medicinal Symposium, June 1984.

 

   50.    Dajani EZ: Antidiarrheal drugs.  An invited presentation delivered at a symposium entitled "Newer Gastrointestinal Drugs," sponsored by The Amer Chem Soc. Philadelphia, Pennsylvania.  August 1984.

 

 51.     Tapper EJ, Dajani EZ, Polk RC: Dose-response duodenal ulcer healing by prostaglandin E1 analog.  International Congress of Gastroenterology.  Lisbon, Portugal.  September 1984.

 

 52.     Agrawal NM, Godiwala T, Arimura A, Dajani EZ: Cytoprotection by prostaglandin E1 analog on ethanol-induced gastric mucosal damage in man.  Amer J Gastroenterology 79: 824, 1984.

 

 53.     Dajani EZ: Non-prostanoids as cytoprotective agents.  An invited presentation, Mexican Gastroenterological Association Meeting.  Guadalajara, Mexico.  December 1984.

 

 54.     Dajani EZ: Mucosal cytoprotection: Clinical models. An invited presentation, Mexican Gastroenterological Association Meeting. Guadalajara, Mexico.  December 1984.

 

 55.     Dajani EZ: Recent advances in the pathophysiology of peptic ulcer disease. An invited presentation, European Association for Gastroenterology and Endoscopy, 17th Congress.  Berlin, West Germany.  March 1985.

 

 56.     Dajani EZ, Bianchi RG, Colton DG, Callison DA, Driskill DR, Phillips EL, Kessler L, Gullikson GW, Woods EM, Collins PW, Pappo R: Perspectives on the pharmacology of misoprostol.  An invited presentation, Fifth International Conference on Experimental Ulcer.  Boston, Massachusetts.  May 1985.  Dig Dis Sci 30: 371, 1985.

 

 57.     Assad RT, Dodd DC, Dajani EZ: Effect of misoprostol, a prostaglandin E1 analog, on epithelial proliferation of canine fundic mucosa. Gastroenterology 88: 1310, 1985.

 

 58.     Assad RT, Dodd DC, Dajani EZ: Effects of misoprostol, a prostaglandin E1 analog, on DNA synthesis of canine fundic mucosa.  Gastroenterology 88:1310, 1985.

 

 59.    Agrawal NM, Godiwala T, Arimura A, Dajani EZ: Adaptive cytoprotection of the human gastric mucosa in response to ethanol injury. Gastroenterology 88:1496, 1985.

 

 60.     McGuigan JE, Chang Y, Deysach L, Dajani EZ: Serum gastrin in patients with duodenal ulcer treated with misoprostol.  Gastroenterology  88:1496, 1985.

 

 61.     Pitzele BS, Yu SS, Hamilton RW, Moorman AE, Gullikson GW, Bianchi RG, Palicharla P, Dajani EZ: Potential antisecretory antidiarrheals, alpha-2 adrenergic agonists related to clonidine.  Amer Chem Soc. Chicago, Illinois.  September 1985.

 

62.         Agrawal NM, Godiwala T, Arimura A, Dajani EZ: Comparative cytoprotection against   ethanol-induced gastric mucosal damage: Misoprostol vs. cimetidine.  Amer J of Gastroenterology 80: 860, 1985.

 

 63.     Larsen KE, Dajani EZ, Muka M: Effects of misoprostol, 16, 16-dimethyl PGE2 and cimetidine on mucosal blood flow and oxygen consumption in the dog ex vivo gastric chamber.  Dig Dis Sci 31:142S, 1986.

 

 64.     Agrawal NM, Godiwala T, Arimura A, Dajani EZ: Comparative effects against alcohol insult: Misoprostol vs. cimetidine.  Dig Dis Sci  31:142S, 1986.

 

 65.     McGuigan JE, Chang Y, Dajani EZ: Effect of misoprostol, an antiulcer prostaglandin, on serum gastrin in patients with duodenal ulcer.  Dig Dis Sci 31:PS120, 1986.

 

 66.     Dajani EZ: Pharmacology of misoprostol.  Three lectures delivered in Birmingham, Leeds and London, U.K., as part of regional continuing medical education symposia entitled "Prostaglandins in Peptic Ulcer."  February 1986.

 

 67.     Dajani EZ: Cytoprotection and acid peptic diseases. An invited presentation, European Association for Gastroenterology and Endoscopy, 18th Congress. Berlin, West Germany.  March 1986.

 

 68.     Gullikson GW, Anglin C, Kessler L, Smeach S, Bauer R, Dajani EZ: Misoprostol prevents aspirin-induced changes in potential difference and associated damage in canine Heidenhain pouches.  An invited presentation, Canadian Association of

           Gastroenterology.  Toronto, Canada.  April 1986.

 

 69.     Dajani EZ: The role of prostaglandins in the maintenance of mucosal integrity.  An invited presentation, Canadian Association of Gastroenterology.  Toronto, Canada.  April 1986.

 

 70.     Dajani EZ: Prostaglandins and their actions on the gastrointestinal tract. Royal Australian College of Physicians Satellite Seminar on Prostaglandins.  Hobart, Tasmania.  May 1986.

 

 71.     Dajani EZ: Prostaglandins: Pharmacology, mechanisms and applications in acid peptic diseases.  An invited presentation, Seventh Icelandic Congress of Internal Medicine.  Reykjavik, Iceland.  May 1986.

 

72.      Dajani EZ: Perspective on the gastric antisecretory effects of misoprostol in man.  Sixth International Conference on Prostaglandins and Related Compounds.  Florence, Italy.  June 1986.

 

73.             Dajani EZ: Gastrointestinal cytoprotective activities of misoprostol: Clinical efficacy overview.  Sixth International Conference on Prostaglandins and Related Compounds.  Florence, Italy.  June 1986.

 

74.      Reimann HJ, Wendt P. Blueml G, Schmidt U, Ohe MVD, Dajani EZ, Wehrschütz E: Misoprostol prevents damage to the gastroduodenal mucosa by stabilizing the mast cells.  Sixth International Conference on Prostaglandins and Related Compounds. Florence, Italy.  June 1986.

 

 75.     Dajani EZ: Clinical cytoprotective actions of misoprostol. An invited presentation, Italian Society of Gastroenterology. Verona, Italy.  June 1986.

 

 76.     Dajani EZ: Prostaglandins in acid peptic disorders.  An invited lecture presented at a post-graduate course sponsored by the European Society of Gastroenterology and Endoscopy.  Cologne, W. Germany.  October 1986.

 

 77.     Dajani EZ: Misoprostol: Pharmacology, mechanism and applications in peptic ulcer disease.  An invited lecture presented at a symposium entitled "International Symposium on Cytoprotection of the Gastroduodenal Mucosa," Inter-American Society of Clinical Pharmacology and Therapeutics/Latin American Association of Pharmacology.  Buenos Aires, Argentina.  November 1986.

 

 78.     Dajani EZ: Overview of misoprostol clinical safety.  An invited lecture presented at a symposium entitled "Prostaglandins and Peptic Ulcer Disease," Hong Kong Society of Internal Medicine.  Hong Kong.  December 1986.

 

 79.     Dajani EZ: Pharmacology of misoprostol: Antisecretory plus mucosal protective activity for an antiulcer agent.  An invited lecture presented at the European Society of Gastroenterology and Endoscopy, Milan, Italy, June 1986.  Italian Journal of Gastroenterology 19 (Suppl. 3): 19S, 1987.   

 

 80.     Dajani EZ: Prostaglandins in gastroenterology.  An invited presentation. Chinese Society of Gastroenterology.  Kunming, People's Republic of China.  November 1987.

 

 81.     Dajani EZ: Prostaglandins: An update. An invited presentation.  American College of Physicians PostGraduate Course.  Keystone, Colorado.  February 1988.

 

 82.     Dajani EZ: Prostaglandins and NSAIDs gastropathy.  An invited presentation.  Pakistan Society of Gastroenterology and Gastrointestinal Endoscopy.  Rawalpindi, Pakistan.  March 1988.

 

 83.     Dajani EZ: Prostaglandins in gastroenterology.  An invited presentation.  European Society of Gastroenterology.  Milan, Italy.  April 1988.

 

 84.     Dajani EZ, McGuigan JE, Chang Y: Effect of the antiulcer prostaglandin misoprostol on serum gastrin in patients with duodenal ulcer.  Postgraduate Medical J 64: 79(Abstract), 1988.

 

 85.     Dajani EZ: Prostaglandins and mucosal protection: An update. An invited presentation.  Amer Association of Colleges of Pharmacy.  Chicago, Illinois.  July 1988.

 

 86.     Dajani EZ, Lanza F: Endoscopic comparison of the protective effects of misoprostol, cimetidine and sucralfate on nonsteroidal anti-inflammatory drugs induced gastrointestinal mucosal injury.  Endoscopy 20: 83 (Abstract), 1988.

 

 87.     Dajani EZ: Prostaglandins and NSAIDs gastropathy. An invited presentation.  1988 International Congresses of Gastroenterology and Digestive Endoscopy.  Rome, Italy.  September 1988.

 

 88.     Dajani EZ:  Prostaglandins.  An invited presentation.  The USSR Cardiology Research Center at the USSR Academy of Medical Sciences.  Moscow, USSR. February 1989.

 

 89.     Dajani EZ: Protective and therapeutic effects of prostaglandins.  An invited presentation given at a Symposium entitled "NSAID Damage of the Upper Gastrointestinal Tract." Third Interscience World Conference on Inflammation.  Monte Carlo, Monaco.  March 1989.

 

90.           Dajani EZ: Prostaglandins and nonsteroidal anti-inflammatory drugs: Pharmacology and mechanism of action.  An invited presentation.  Prostaglandins Telesymposium.  University of Puerto Rico.  San Juan, Puerto Rico.  May 1989.

 

 91.     Dajani EZ: Prostaglandins in surgical diseases.  An invited presentation.  Department of Surgery.  Rush-Presbyterian St. Lukes Medical Center. Chicago, Illinois.  June 1989.

 

 92.     Dajani EZ: Overview on the mechanisms of cytoprotection by misoprostol.  An invited presentation at the International Symposium on Cell Injury and Cytoprotection.  Harvard Medical School. Boston, Massachusetts.  July 1989.

 

 93.     Dajani EZ: Prostaglandins and the esophagus: Pharmacological and therapeutic perspectives. An invited presentation.  International Symposium on Esophageal Diseases.  Taormina, Italy.  September 1989.

 

 94.     Dajani EZ: Prostaglandins and nonsteroidal anti-inflammatory drugs: Pharmacology, mechanisms of action and future prospects.  An invited presentation.  International Symposium on Esophageal Diseases.  Taormina, Italy.  September 1989.

 

95.             Dajani EZ: Prostaglandins and mucosal protection: Current and future perspectives.  Visiting Professor Lecture Series, Department of Pharmacology and Toxicology.  Purdue University, West Lafayette, Indiana, November 1989.

 

 96.     Downie WW, Dajani EZ: NSAID-induced gastropathy: Treatment.  Second International Congress of Rheumatology.  Manila, Philippines.  December 1989.

 

97.           Dajani EZ: Prostaglandins: Visiting Professor. Departments of Medicine and Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, December 1989.

 

 98.     Dajani EZ: Prostaglandins and gastroenterology.  An invited presentation.  Louisiana Gut Club, New Orleans, Louisiana, February 1990.

 

99.      Dajani EZ: Prostaglandins: Current and future perspectives regarding

gastric mucosal protection.  American College of Physicians.  Post Graduate Course, Keystone, Colorado, February 1990.

 

100.    Dajani EZ: Historical perspectives on the discovery and development of misoprostol: A pharmacologist odyssey.  An invited presentation.  Second International Symposium on Experimental and New Therapeutic approaches to Ulcer Diseases.  Pecs, Hungary, July 1990.

 

101.         Dajani EZ: Pharmaceutical industry perspectives on the discovery and development of antiulcer drugs.  Chairman of a Round Table Discussion.  Presented at the Second International Symposium on Experimental and New Therapeutic Approaches to Ulcer Disease.  Pecs, Hungary, July 1990.

 

102.    Dajani EZ: Prostaglandins: Current and future medical developments.  An invited presentation.  Departments of Medicine and Surgery, Hines Veteran Administration Medical Center.  Hines, Illinois, July 1990.

 

103.    Dajani EZ: Prostaglandins: Past, present and future.  An invited presentation celebrating the tenth anniversary of Donald E. Wilson, MD as a Chairman of the Department of Medicine, State University of New York, Health Science Center, Brooklyn, NY, September, 1990.

 

104.    Agrawal NM, Dajani EZ, Stromatt S, Brown J: Misoprostol vs. sucralfate for the prophylaxis of NSAID-induced gastric mucosal damage: Result of acute and chronic administration.  Amer J Gastroenterol 85 (9): 1228 (Abstract), 1990.

 

105.    Dajani EZ: Prostaglandins in acid peptic disorders. An invited presentation.  Second Symposium on Experimental Ulcer Disease.  Otocec (Slovenia), Yugoslavia, November 1990.

 

106.         Dajani EZ: Prostaglandins in acid peptic disorders: An overview of the worldwide clinical experience: An invited lecture.  American College of Physicians PostGraduate Course, Keystone, Colorado, February 1991.

 

107.   Agrawal NM, Stromatt S, Dajani EZ: Comparative efficacy of misoprostol and sucralfate in preventing gastric ulcers in patients on chronic NSAIDs therapy: Role of gastric erosion as a predictor for the development of ulcers.  Seventh International Conference on Experimental Ulcer.  Berlin, Germany, October 1991.

 

108.    Dajani EZ, Agrawal NM: Prevention of NSAID-induced gastric damage: Effect of prostaglandins and mucosal coating compounds.  Joint Meeting of the Mediterranean Society of Clinical Pharmacology and the Italian Society of Gastroenterology.  Venice, Italy, October, 1991.

 

109.        Agrawal NM, Dajani EZ: Misoprostol is superior to sucralfate in preventing NSAID-induced gastric ulcer in patients with osteoarthritis: Importance of erosions. J Association for Academic Minority Physicians 2: 179, 1991.

 

 110.    Agrawal N, Meckstroth S, Dajani EZ: Clinical significance of gastric erosions as a predictor of NSAID-induced ulcers.  Gastroenterology 102:Al, 1992.

 

111.    Dajani EZ: Clinical use of prostaglandins in ulcer therapy.  An invited presentation.  FASEB/AGA Summer Research Conference entitled "Molecular Basis of Gastric Mucosal Defense."  Copper Mountain, Colorado, July 1992.

 

112.    Dajani, EZ: Predictive Models For the Evaluation of Anti-ulcer and Cytoprotective Drugs in Healthy Human Subjects.  An invited presentation. Italian Society of Pharmacology: Clinical Pharmacology Section, Udine, Italy, September 1993.

 

113.    Dajani, EZ: Prostaglandins in Gastroenterology: An Update. Invited presentation. Second Osaka International Symposium on Gastroenterology.  Osaka, Japan, November 1993.

 

114.    Dajani, EZ: Prostaglandins in Medicine. Visiting Professor Lecture 

           Series.  Invited presentation.  Osaka City University Medical

            School.  Osaka, Japan, November 1993.

 

115. Kobayashi K, Dajani EZ, Itoh M, Arakawa T: Second Osaka International symposium on Gastroenterology: Symposium Synopsis.  Dig Dis Sci 39 (4): 897-898, 1994.

 

116.      Dajani EZ, Agrawal NM: Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs.